Skip to main content

Becton Dickinson EMEA revenue

  • BDX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$218.03+1.08%Close 13 Nov 2026 · Market value $59.20B

EMEA revenue at Becton Dickinson came to $4.7B for the fiscal year to 30 Sep 2025, up 7.4% from a year earlier.

As Becton Dickinson reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 25 Nov 2025.

By fiscal year

$3.8BSep 2019$3.7BSep 2020$4.5BSep 2021$4.0BSep 2022$4.2BSep 2023$4.4BSep 2024$4.7BSep 2025
Becton Dickinson EMEA revenue, every reported period
Period endingEMEA revenueChange on a yearFiled
30 Sep 2025$4.7Bup 7.4%25 Nov 2025
30 Sep 2024$4.4Bup 3.7%27 Nov 2024
30 Sep 2023$4.2Bup 5.0%21 Nov 2023
30 Sep 2022$4.0Bdown 11.1%22 Nov 2022
30 Sep 2021$4.5Bup 21.8%24 Nov 2021
30 Sep 2020$3.7Bdown 2.7%25 Nov 2020
30 Sep 2019$3.8B—27 Nov 2019

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Becton Dickinson: Medical revenue · Medical Essentials revenue · Interventional revenue · Life Sciences (earlier basis) revenue · Connected Care revenue · BioPharma Systems revenue · Greater Asia revenue · United States revenue · International revenue · financial statements

Every KPI and segment of BDX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.